Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Metra Biosystems enters talks with unnamed buyer:

This article was originally published in Clinica

Executive Summary

Diagnostic company Metra Biosystems is negotiating with an unnamed buyer. The companies have entered into an initial 30-day period of exclusivity to form a definitive agreement. Mountain View, California-based Metra develops products for the detection and management of metabolic bone diseases and disorders. Late last year, Metra announced plans to merge with fellow point-of-care diagnostics company Spectral Diagnostics, only to call the deal off within two months (see Clinica No 845, p 8).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel